IMMUPHARMA
IMMUPHARMA operates in Diversified Metals & Mining.
Market Cap & Net Worth: IMMUPHARMA (25I)
IMMUPHARMA (BE:25I) has a market capitalization of $571.96 (€557.21) as of March 18, 2026. Listed on the BE stock exchange, this Germany-based company holds position #48689 globally and #8177 in its home market, demonstrating a -3.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IMMUPHARMA's stock price €0.06 by its total outstanding shares 9525 (9.53K).
IMMUPHARMA Market Cap History: 2015 to 2025
IMMUPHARMA's market capitalization history from 2015 to 2025. Data shows change from $3.61K to $571.96 (-16.84% CAGR).
IMMUPHARMA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IMMUPHARMA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
IMMUPHARMA's market cap is 0.01 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.15K | $164.78K | -$5.32 Million | 0.03x | N/A |
| 2017 | $18.29K | $150.46K | -$6.22 Million | 0.12x | N/A |
| 2018 | $1.27K | $81.28K | -$7.21 Million | 0.02x | N/A |
| 2019 | $1.78K | $77.92K | -$6.12 Million | 0.02x | N/A |
| 2020 | $1.25K | $126.67K | -$6.86 Million | 0.01x | N/A |
| 2021 | $682.45 | $118.35K | -$8.17 Million | 0.01x | N/A |
Competitor Companies of 25I by Market Capitalization
Companies near IMMUPHARMA in the global market cap rankings as of March 18, 2026.
Key companies related to IMMUPHARMA by market ranking:
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2321 globally with a market cap of $6.45 Billion USD ( €6.29 Billion EUR).
- BERKSHIRE HATH-A (BE:BRH): Ranked #2330 globally with a market cap of $6.40 Billion USD ( €6.24 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2321 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.45 Billion | €638000.00 |
| #2330 | BERKSHIRE HATH-A | BE:BRH | $6.40 Billion | €634500.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
IMMUPHARMA Historical Marketcap From 2015 to 2025
Between 2015 and today, IMMUPHARMA's market cap moved from $3.61K to $ 571.96, with a yearly change of -16.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €571.96 | +350.00% |
| 2024 | €127.10 | -18.75% |
| 2023 | €156.43 | -23.81% |
| 2022 | €205.32 | -69.91% |
| 2021 | €682.45 | -45.25% |
| 2020 | €1.25K | -29.79% |
| 2019 | €1.78K | +39.69% |
| 2018 | €1.27K | -93.05% |
| 2017 | €18.29K | +255.03% |
| 2016 | €5.15K | +42.82% |
| 2015 | €3.61K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of IMMUPHARMA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $571.96 USD |
| MoneyControl | $571.96 USD |
| MarketWatch | $571.96 USD |
| marketcap.company | $571.96 USD |
| Reuters | $571.96 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.